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Background/aim: In this study, it was aimed to investigate the effects of pulsed electromagnetic field (PEMF) therapy on pain, disability,
psychological state, and quality of life in cervical disc herniation.
Materials and methods: Patients were randomly divided into two groups, including Group 1, which received a therapy consisting of
transcutaneous electrical nerve stimulation (TENS), hot pack (HP), and PEMF, and Group 2, which received a magnetic field (sham
magnetic field) without current flow in addition to TENS and HP therapy. Pain was assessed by a visual analog scale (VAS, 0–10
cm). The other outcome measures were function (Neck Pain and Disability Scale), anxiety-depressive mood (Hospital Anxiety and
Depression Scale), and quality of life (Nottingham Health Profile). All evaluations were performed at baseline, in the 3rd week, and in
the 12th week after treatment.
Results: A significant improvement was found in the neck pain, disability, depression, anxiety, and quality of life scores of both groups
after treatment when compared to those before treatment. However, in the comparison between changes within groups, significant
improvements were determined only in the VAS and Nottingham Health Profile sleep subparameter in the 12th week after treatment
compared to those before treatment.
Conclusion: PEMF therapy in cervical disc herniation can be used safely in routine treatment in addition to conventional physical
therapy modalities.
Key words: Pulsed electromagnetic fields, cervical disc herniation, pain, quality of life

1. Introduction
Neck pain leads to functional limitations and inadequacies
by affecting the daily life activities of individuals negatively
[1,2]. Cervical disc herniation (CDH) is one of the
significant causes of neck pain, which occurs as a result of
the nucleus pulposus leaking out of the annulus fibrosis,
which is ruptured for various reasons, and creating
pressure on the spinal cord and nerve roots [3].
Pulsed electromagnetic field (PEMF) therapy is a
noninvasive, inexpensive, and safe physical therapy agent
with no known significant side effects. Its beneficial effects
in many musculoskeletal diseases, such as fracture healing,
nerve regeneration, osteoarthritis, fibromyalgia, and
osteoporosis, have been revealed [4–8].
PEMF therapy has been demonstrated to be effective
in the treatment of many diseases, especially locomotor
system diseases, because of its antiinflammatory,
antiedema, analgesic, antispasmodic, and blood-boosting
effects [9–12]. PEMF therapy has been reported to

show these effects through its regulatory effects on the
stimulation of lysosomes, hormone secretion, regulation
of enzymatic activities, increase of DNA and collagen
synthesis, regulation of calcium metabolism, receptor
modification and membrane permeability, and materials
such as adenylyl cyclase, cAMP, and protein kinase [9–11].
There are limited studies evaluating the effects of PEMF
therapy on pain and disability in cases of mechanical
neck pain and cervical osteoarthritis. However, we did
not encounter any study evaluating the efficacy of PEMF
therapy only in the treatment of CDH. In the present
study, it was aimed to investigate the efficacy of PEMF
therapy on pain, disability, psychological state, and quality
of life in CDH.
2. Materials and methods
In this prospective, placebo-controlled, randomized
double-blind study, volunteer patients between 18 and
65 years of age diagnosed with CDH, who were admitted
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to the Dicle University Faculty of Medicine Physical
Medicine and Rehabilitation Outpatient Clinic between
September 2016 and August 2017 with the complaint of
neck and arm pain for more than 2 months and in whom
intervertebral disc protrusion or extrusion was detected in
magnetic resonance imaging (MRI) of the cervical region,
were included. Before the study, approval was obtained
from the Ethics Committee of the Dicle University Faculty
of Medicine. All the recruited subjects signed an informed
consent form before participating in the study.
Patients who had received physical therapy within
3 months, those using analgesics or nonsteroidal
antiinflammatory drugs, those with neurological deficits,
and patients who were diagnosed with cervical myelopathy
or cervicobrachial syndrome were excluded from the study.
Furthermore, patients with previous cervical surgery,
with inflammatory diseases such as rheumatoid arthritis
or ankylosing spondylitis, and those with osteoporosis,
fibromyalgia, myofascial pain syndrome, thoracic outlet
syndrome, cancer, chronic liver disease, chronic kidney
disease, chronic heart disease, or psychiatric diseases were
also not included in the study. Female patients who might
have been pregnant were also excluded from the study.
The detailed anamnesis of the patients was obtained,
and their demographic characteristics were recorded.
Complete blood count, erythrocyte sedimentation rate,
serum C-reactive protein (CRP), and routine biochemical
analyses were determined.
The present study was designed as a prospective,
double-blinded randomized controlled trial with three
measurement points (baseline, 3rd week, and 12th week
after treatment). Seventy-four patients who met the
eligibility criteria were randomly allocated to either the
intervention group (Group 1) or control group (Group
2). Randomization was applied with a simple random
approach by using a table of random numbers.
Group 1 received therapy consisting of transcutaneous
electrical nerve stimulation (TENS), a hot pack (HP), and
PEMF. Group 2 received a magnetic field (sham magnetic
field) without current flow in addition to TENS and HP
therapy.
The patients did not know what treatment they were
receiving. The treatments were applied by the same
technician. The evaluation of the patients was performed
by the same physician, who did not know which groups
patients were in.
HP and TENS were applied together for 20 min. TENS
was applied to the paravertebral muscles by a dual-channel
Chattanooga Intelect Advanced Monochromatic Combo
electrotherapy device with two carbon electrodes, and the
highest level of current that the patient could tolerate was
delivered in the conventional mode (frequency 100 Hz,
current duration 40 ms).
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PEMF therapy was applied to the cervical region by ASA
EASY Quattro PRO (Arcugnano, Italy). Magnetotherapy
was applied at low frequency (50 Hz), with intensity of
0.6 mT and application time of 20 min. The control group
(Group 2) received a magnetic field (sham magnetic field)
without current flow in addition to TENS and HP therapy.
This therapy program was implemented 5 days a week for
3 weeks.
In both groups, the use of analgesics was not allowed,
except for a maximum of 2000 mg/day of paracetamol.
A visual analogue scale (VAS) was used to determine
the severity of pain. The VAS is a 10-cm line; the left end
indicates no pain while the right end indicates intolerable
pain [13].
Pain and related disability during the daily life activities
of the patients were assessed by the Neck Pain and Disability
Scale (NPDS), the reliability and validity of which were
tested in Turkish people [14]. The NPDS consists of a
20-item questionnaire addressing neck problems, pain
intensity, emotion and cognition, and interference with
life activities. Each item is scored between 0 and 5 (0: no
pain or activity limitation, 5: as much pain as possible
or maximal limitation), and the maximum score is 100.
Higher scores indicate a worse quality of life [15].
The Hospital Anxiety and Depression (HAD) scale
was used to measure the depression and anxiety levels of
the patients. The HAD scale is a 14-item questionnaire.
The questionnaire comprises seven questions for anxiety
and seven questions for depression (score range: 0–21).
Seven was found to be the cut-off score for the depression
subscale and 10 for the anxiety subscale [16,17]. The
validity and reliability studies of the Turkish version of the
HAD scale were performed by Aydemir et al. [17].
The patient’s quality of life was assessed by the
Nottingham Health Profile (NHP) questionnaire. This
scale is a 38-item questionnaire with 6 subareas, and it
evaluates energy level, pain, emotional reaction, sleep,
social isolation, and physical abilities. Each question is
answered by “yes” or “no” with each question assigned a
weighted value. The items are scored from 0 to 100. Higher
scores indicate a worse quality of life. The validity and
reliability studies of the Turkish version of the NSP were
performed by Küçükdeveci et al. [18].
2.1. Statistical analysis
The data were analyzed using SPSS 18 (SPSS Inc., Chicago,
IL, USA). The Kolmogorov–Smirnov test was used to
test for normality. Quantitative variables are presented as
mean (x) ± standard deviation (SD), whereas categorical
variables are presented as number and %. Comparisons
between the groups were made by the independentsamples t-test or Mann–Whitney U test according to the
compatibility of the data with normal distribution. The
difference between proportional variables was calculated
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by the chi-square test. Changes over time of more than
two measurements in the groups were calculated by the
repeated measures analysis of variance method. The
hypotheses were bidirectional, and P ≤ 0.05 was considered
statistically significant.
3. Results
The patients were recruited from September 2016 to
August 2017. Of the 140 patients, 42 patients did not
meet the inclusion criteria, and 3 patients did not agree to
participate in the study. The study included 74 patients. Five
patients in each group dropped out for different reasons.
Thus, 64 patients completed the study. The Consolidated
Standards of Reporting Trials (CONSORT) flow diagram
of the study is presented in the Figure.
3.1. Demographic data
There were 22 (68.8%) females and 10 (31.3%) males in
Group 1, and 24 (75%) females and 8 (25%) males in
Group 2. The demographic characteristics of Group 1 and
Group 2 are listed in Table 1.
When the groups were compared in terms of the size
of the disc herniation, there was no significant difference

between the groups. While 30 patients had protruded
herniation and two patients had extruded herniation in
Group 1, 27 patients had protruded herniation and five
patients had extruded herniation in Group 2 (P = 0.23).
3.2. Pain and function
There was no significant difference in terms of the VAS (0–
10 cm) pain and NPDS function scores before treatment
in both groups. Significant improvement was observed in
both groups in week 3 and week 12 after treatment. Upon
comparing the groups, there was no significant difference
in terms of the NPDS scores, and when the changes within
the groups were compared in terms of VAS in week 12, it
was indicated that there was a significant improvement in
Group 1 (Table 2).
3.3. Anxiety and depression
There was no significant difference between the groups
in the HAD-Anxiety and Depression Scale scores before
treatment. In the third week after treatment, the HAD
anxiety scores significantly improved in both groups;
however, a significant difference was found only in
Group 1 in the 12th week after treatment. There was no

Figure. Patient flow chart
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Table 1. The demographic characteristics of the groups (mean ± SD or n, %).
Group 1 (n = 32)

Group 2 (n = 32)

P

Age (years)

42.96 ± 10.35

47.15 ± 11.03

0.12

Sex (male, %)

10 (31.3)

8 (25)

0.57

BMI (kg/m2)

28.29 ± 4.95

27.38 ± 4.47

0.44

Symptom duration (years)

3.58 ± 5.52

3.50 ± 3.83

0.54

Table 2. Pain and function of groups.
Group 1 (n = 32)

Group 2 (n = 32)

P (MWU)

Pain (VAS 0–10 cm)
Baseline
3rd week
12th week

		 pA
7.09 ± 1.67
3.62 ± 2.59 †		 <0.001*
4.78 ± 2.80 ‡

		pA
7.37 ± 1.69
4.43 ± 2.39 †
<0.001*
6.25 ± 2.44 ‡

0.57
0.19
0.02*

Change (0–12)

2.31 ± 2.30

1.12 ± 1.99

0.03*

Function (NPDS)

		pA

		pA

Baseline

60.25 ± 17.01

61.12 ± 19.47

3rd week

42.03 ± 21.58 †		 <0.001*

44.53 ± 20.81 †

12th week

48.37 ± 22.30 ‡

54.34 ± 20.74 ‡

0.84
<0.001*

0.63
0.27

MWU: Mann–Whitney U test, A: ANOVA, †: baseline - 3rd week, ‡: baseline - 12th week differences
within groups (Wilcoxon signed ranks test/paired samples test), * P < 0.05.

significant difference between the two groups in the 3rd
and 12th weeks when the groups were compared (Table 3).
While a significant improvement was found in the HAD
depression scores in Group 1 in the 3rd and 12th weeks
after treatment, no significant difference was found in
Group 2 (Table 3).
3.4. Quality of life
Before treatment, there was no significant difference
between the two groups in terms of all NHP
subparameters, except for the NHP total score. While
there was a significant improvement in the pain, physical
activity, energy, sleep, and total NHP scores in Group 1
in the 3rd and 12th weeks after treatment, there was a
significant improvement in pain and emotional reaction
scores in Group 2 (Table 4).
While there was no significant difference in terms of
social isolation in Group 1 in the 3rd and 12th weeks after
treatment, there was no significant difference in sleep,
physical activity, and energy subparameters in Group 2
(Table 4).
When the 2 groups were compared, while physical
activity, energy level, and total scores in the NHP
significantly improved in Group 1, social isolation and
emotional reaction were significantly improved in Group
2 at 3 and 12 weeks. When the changes within the groups
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were compared, a significant improvement was observed
in the sleep subparameter in Group 1 only in the 12th week
after treatment when compared to that before treatment.
No significant difference was found in the comparison of
other parameters (Table 4).
4. Discussion
In this study, while the addition of PEMF therapy to
the conventional physical therapy program in patients
with CDH provided an improvement in pain and sleep
in the 12th week, its additional contribution to function,
general quality of life, anxiety, and depression could not
be demonstrated.
In a study evaluating the efficacy of PEMF therapy
on pain, joint range of motion, and functional status in
cervical osteoarthritis patients, significant improvements
were found in pain, muscle spasm, joint movements, and
NPDS scores in the treatment group compared to the
control group [19]. In another placebo-controlled study
in which the efficacy of PEMF therapy was evaluated in
patients with chronic neck pain, a significant improvement
in neck pain and joint range of motion was observed in
patients receiving PEMF therapy compared to the control
group. Furthermore, it was stated that PEMF therapy could
be used easily in the treatment of chronic neck pain due
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Table 3. Anxiety-depression and moods of groups.
Group 1 (n = 32)
Anxiety-depression Mood
HAD-Anxiety
Baseline
3rd week
12th week

Group 2 (n = 32)

pA

pA

7.59 ± 3.42
6.46 ± 2.91† 0.006*
6.78 ± 2.77 ‡

HAD-Depression

P (MWU)

7.50 ± 3.77
6.53 ± 3.13 † 0.01*
6.87 ± 3.46

pA

0.91
0.93
0.90

pA

Baseline

7.56 ± 2.63

7.75 ± 3.21

3rd week

6.65 ± 3.38 † 0.03*

7.06 ± 3.55

12th week

6.87 ± 3.03 ‡

7.43 ± 3.11

0.79
0.08

0.64
0.69

MWU: Mann–Whitney U test, A: ANOVA, †: baseline - 3rd week, ‡: baseline - 12th week differences
within groups (Wilcoxon signed ranks test/paired samples test), * P < 0.05.

to the absence of side effects [20]. Similarly, in our study,
significant improvements were found in the pain scores of
the patients between the period before treatment and the
12th week after treatment compared to the control group.
This result may indicate that the effects of PEMF therapy
appear in the late period. It is possible to attribute this
late effect to the mechanisms of action of PEMF therapy
(stimulation of lysosomes, hormone secretion, regulation
of enzymatic activities, increase of DNA and collagen
synthesis, regulation of calcium metabolism, receptor
modification and membrane permeability, regulation of
materials such as adenylyl cyclase, cAMP, protein kinase)
[9–11].
In a study carried out by Lee et al., the effects of the
electromagnetic field on the proliferation of human
intervertebral disc (IVD) cells were investigated, and
the electromagnetic field was found to stimulate DNA
synthesis in IVD cells. Thus, the researchers concluded
that the electromagnetic field could be used to stimulate
the proliferation of IVD cells in the cellular treatment of
degenerative disc disease [21]. In another study, it was
emphasized that PEMF therapy had significant impacts
on the expression of genes associated with the early stages
of inflammation and some effects on genes associated
with matrix degradation. The effects of PEMF on
proinflammatory cytokine and MMP expression highlight
a potential role of PEMF in the treatment of inflammation
in IVDs. Moreover, the authors concluded that IVD cells
are responsive to PEMF and future studies are warranted
to determine whether PEMF may be helpful for patients
with IVD degeneration [22]. In our study, we can explain
the positive effects of PEMF therapy on pain in patients
with CDH by these mechanisms.
Neck pain leads to functional limitations and
disabilities by influencing physical and psychological

functions. Moreover, it causes difficulties in daily life
activities [1,23]. In the evaluation made within Group
1, a significant decrease was found in both the anxiety
and depression scores before and after treatment and
in the 12th week after treatment. However, there was
no significant difference in the HAD scores between
the two groups in the comparison between the groups
in differences before and after treatment. In the study
carried out by Boskovic et al., it was found that PEMF and
laser treatments did not cause heat and electric sensation
in patients, and therefore they were not very good at
eliminating psychoneurotic symptoms compared to other
treatment methods, but they were effective on vascular or
neurological cervical syndromes [24]. Similarly, one of the
reasons for the absence of a significant difference between
the groups in our study may be that PEMF therapy does
not create any felt sense in patients.
Chronic neck pain not only causes weakness of the
neck muscles but also decreases the quality of life [25].
In our study, in the evaluation made within Group 1, a
significant improvement was observed in all parameters,
except for the NHP-social isolation and NHP-emotional
reaction subparameters. Furthermore, in the evaluation
between the changes within groups, an improvement only
in the NHP-sleep subparameter was found to be significant
in the 12th week after treatment compared to that before
treatment. Poor sleep quality is strongly related to chronic
pain [26]. As a result, a decrease in pain in the 12th week
after treatment in our patients may have contributed
positively to sleep.
The present study had certain limitations. The first
limitation of the study is the assessment of short-term
but not long-term effects of treatment. The second one
is the usage of TENS and HP therapies together and
not evaluating the effect of PEMF therapy alone since
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Table 4. Quality of life in groups.
NHP

Group 1 (n = 32)

Group 2 (n = 32)

P (MWU)

NHP-P
Baseline
3rd week
12th week

		pA
63.59 ± 28.78
38.93 ± 34.76 †
<0.001*
47.28 ± 35.01‡

71.12 ± 32.29
53.21 ± 36.63†
62.59 ± 32.88‡

Baseline

30.59 ± 27.89

41.71 ± 35.50

3rd week

21.50 ± 23.85†

12th week

25.56 ± 25.42

38.50 ± 36.03

0.10

Baseline

33.71 ± 32.62

46.90 ± 34.94

0.12

3rd week

17.78 ± 26.90†

12th week

22.71 ± 28.27‡

45.53 ± 32.69

0.004*

Change (0–12)

11.00 ± 23.09

1.37 ± 12.66

0.04*

Baseline

18.93 ± 24.18

33.96 ± 38.95

0.06

3rd week

10.31 ± 18.09

12th week

17.18 ± 25.83

35.15 ± 39.18

0.03*

Baseline

27.78 ± 19.87

40.84 ± 30.33

0.05

3rd week

17.37 ±17.56†

12th week

22.06 ± 19.25‡

pA
<0.001*

0.32
0.11
0.07

NHP-ER
0.01

34.37 ± 35.48

0.16
0.007*

0.09

NHP-S
0.001*

39.12 ± 32.59

0.05

0.006*

NHP-SI
0.08

25.84 ± 35.78†

0.007*

0.03*

NHP-PA
0.001*

36.96 ± 32.15

0.25

40.09 ± 28.49

0.04*
0.004*

NHP-EL
Baseline

58.12 ± 34.58

3rd week

39.03 ± 32.87†

72.34 ± 32.51

12th week

49.90 ± 36.74‡

69.90 ±32.33

0.02*

Baseline

233.5 ± 120.6

306.9 ± 164.1

0.04*

3rd week

144.1 ± 116.1†

12th week

183.8 ± 128.3‡

0.001*

66.43 ±36.95

0.09
0.37

0.003*

NHP-T
<0.001*

253.1 ± 172.3†
292.1 ± 162.6

0.001*

0.004*
0.004*

MWU: Mann–Whitney U test, A: ANOVA, †: baseline - 3rd week, ‡: baseline - 12th week differences
within groups (Wilcoxon signed ranks test/paired samples test), * P < 0.05. P: Pain, ER: emotional
reaction, S: sleep, SI: social isolation, PA: physical activity, EL: energy level, T: total.

they have similar efficacy. The third one is the limited
patient number and sample size not being calculated in
this study. Although during the study the patients were
allowed to use paracetamol up to a maximum of 2000
mg/day when needed, the total paracetamol dose used
by the patients was not recorded. In conclusion, PEMF
therapy in CDH can be used safely in routine treatment
in addition to conventional physical therapy modalities
due to the relatively late onset of the effect. A significant
improvement was found in the neck pain, disability,
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depression, anxiety, and quality of life scores of both
groups after treatment when compared to those before
treatment. Furthermore, in the comparison between the
changes within groups, a significant improvement was
observed in the pain and NHP-sleep subparameter in the
12th week after treatment when compared to those before
treatment. Since parameters such as intensity, frequency,
and frequency of application applied in PEMF therapy
differ in many studies, randomized controlled studies are
needed to standardize these parameters.
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